Multicenter International Cohort Validation of a Modified Sequential Organ Failure Assessment Score Using the Richmond Agitation-sedation Scale.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
pubmed:
18
11
2020
medline:
1
9
2022
entrez:
17
11
2020
Statut:
ppublish
Résumé
In a multicenter, international cohort, we aimed to validate a modified Sequential Organ Failure Assessment (mSOFA) using the Richmond Agitation-Sedation Scale, hypothesized as comparable to the Glasgow Coma Scale (GCS)-based Sequential Organ Failure Assessment (SOFA). The SOFA score, whose neurologic component is based on the GCS, can predict intensive care unit (ICU) mortality. But, GCS is often missing in lieu of other assessments, such as the also reliable and validated Richmond Agitation Sedation Scale (RASS). Single-center data suggested an RASS-based SOFA (mSOFA) predicted ICU mortality. Our nested cohort within the prospective 2016 Fourth International Study of Mechanical Ventilation contains 4120 ventilated patients with daily RASS and GCS assessments (20,023 patient-days, 32 countries). We estimated GCS from RASS via a proportional odds model without adjustment. ICU mortality logistic regression models and c-statistics were constructed using SOFA (measured GCS) and mSOFA (measured RASS-estimated GCS), adjusted for age, sex, body-mass index, region (Europe, USA-Canada, Latin America, Africa, Asia, Australia-New Zealand), and postoperative status (medical/surgical). Cohort-wide, the mean SOFA=9.4+/-2.8 and mean mSOFA = 10.0+/-2.3, with ICU mortality = 31%. Mean SOFA and mSOFA similarly predicted ICU mortality (SOFA: AUC = 0.784, 95% CI = 0.769-0.799; mSOFA: AUC = 0.778, 95% CI = 0.763-0.793, P = 0.139). Across models, other predictors of mortality included higher age, female sex, medical patient, and African region (all P < 0.001). We present the first SOFA modification with RASS in a "real-world" international cohort. Estimating GCS from RASS preserves predictive validity of SOFA to predict ICU mortality. Alternative neurologic measurements like RASS can be viably integrated into severity of illness scoring systems like SOFA.
Sections du résumé
OBJECTIVE
In a multicenter, international cohort, we aimed to validate a modified Sequential Organ Failure Assessment (mSOFA) using the Richmond Agitation-Sedation Scale, hypothesized as comparable to the Glasgow Coma Scale (GCS)-based Sequential Organ Failure Assessment (SOFA).
SUMMARY BACKGROUND DATA
The SOFA score, whose neurologic component is based on the GCS, can predict intensive care unit (ICU) mortality. But, GCS is often missing in lieu of other assessments, such as the also reliable and validated Richmond Agitation Sedation Scale (RASS). Single-center data suggested an RASS-based SOFA (mSOFA) predicted ICU mortality.
METHODS
Our nested cohort within the prospective 2016 Fourth International Study of Mechanical Ventilation contains 4120 ventilated patients with daily RASS and GCS assessments (20,023 patient-days, 32 countries). We estimated GCS from RASS via a proportional odds model without adjustment. ICU mortality logistic regression models and c-statistics were constructed using SOFA (measured GCS) and mSOFA (measured RASS-estimated GCS), adjusted for age, sex, body-mass index, region (Europe, USA-Canada, Latin America, Africa, Asia, Australia-New Zealand), and postoperative status (medical/surgical).
RESULTS
Cohort-wide, the mean SOFA=9.4+/-2.8 and mean mSOFA = 10.0+/-2.3, with ICU mortality = 31%. Mean SOFA and mSOFA similarly predicted ICU mortality (SOFA: AUC = 0.784, 95% CI = 0.769-0.799; mSOFA: AUC = 0.778, 95% CI = 0.763-0.793, P = 0.139). Across models, other predictors of mortality included higher age, female sex, medical patient, and African region (all P < 0.001).
CONCLUSIONS
We present the first SOFA modification with RASS in a "real-world" international cohort. Estimating GCS from RASS preserves predictive validity of SOFA to predict ICU mortality. Alternative neurologic measurements like RASS can be viably integrated into severity of illness scoring systems like SOFA.
Identifiants
pubmed: 33201122
pii: 00000658-202208000-00037
doi: 10.1097/SLA.0000000000004484
pmc: PMC10573707
mid: NIHMS1931473
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e114-e119Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120484
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL111111
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG053264
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG035117
Pays : United States
Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no other conflicts of interest.
Références
Crit Care Med. 2013 Jan;41(1):263-306
pubmed: 23269131
Health Informatics J. 2010 Mar;16(1):35-47
pubmed: 20413411
J Crit Care. 2014 Oct;29(5):780-5
pubmed: 25012961
Crit Care Med. 2002 Feb;30(2):338-42
pubmed: 11889305
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
JAMA. 2002 Jan 16;287(3):345-55
pubmed: 11790214
Crit Care Med. 1999 Sep;27(9):1999-2004
pubmed: 10507631
Ann Emerg Med. 2004 Feb;43(2):215-23
pubmed: 14747811
J Thorac Dis. 2016 May;8(5):E292-4
pubmed: 27162685
N Engl J Med. 2009 Mar 26;360(13):1283-97
pubmed: 19318384
JMIR Med Inform. 2016 Sep 30;4(3):e28
pubmed: 27694098
Am J Respir Crit Care Med. 2012 Oct 15;186(8):724-31
pubmed: 22859526
Am J Respir Crit Care Med. 2002 Nov 15;166(10):1338-44
pubmed: 12421743
JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901
Crit Care Med. 2019 Mar;47(3):307-314
pubmed: 30768498
Crit Care Med. 2016 Jun;44(6):e450
pubmed: 27182877
N Engl J Med. 2004 May 27;350(22):2247-56
pubmed: 15163774
J Crit Care. 2018 Apr;44:212-216
pubmed: 29161667
Crit Care Med. 2016 Jan;44(1):138-46
pubmed: 26457749
Crit Care Med. 2009 Sep;37(9):2527-34
pubmed: 19602975
J Pain Symptom Manage. 2018 Sep;56(3):406-413.e3
pubmed: 29902555
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Am J Respir Crit Care Med. 2008 Jan 15;177(2):170-7
pubmed: 17962636
Can J Anaesth. 2017 Mar;64(3):260-269
pubmed: 28028673
J Anesth. 2011 Dec;25(6):839-44
pubmed: 21931987
Am J Respir Crit Care Med. 2013 Jul 15;188(2):220-30
pubmed: 23631814
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Int J Antimicrob Agents. 2018 Apr;51(4):629-635
pubmed: 29408227
Curr Opin Crit Care. 2012 Dec;18(6):700-6
pubmed: 22954664
Crit Care Med. 1998 Nov;26(11):1793-800
pubmed: 9824069
Lancet Respir Med. 2018 Mar;6(3):183-192
pubmed: 29325753
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
Braz J Med Biol Res. 2013 Feb;46(2):186-93
pubmed: 23369978
JAMA. 2003 Jun 11;289(22):2983-91
pubmed: 12799407
J Thorac Dis. 2016 Mar;8(3):311-3
pubmed: 27076924
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Intensive Care Med. 1999 Jul;25(7):686-96
pubmed: 10470572